Puma Biotech (PBYI) Posts Q2 adj.-Loss of $1.17/Share

Puma Biotech (NYSE: PBYI) reported Q2 EPS of ($1.17), $1.01 better than the analyst estimate of ($2.18).

For earnings history and earnings-related data on Puma Biotech (PBYI) click here.

You May Also Be Interested In

• SanDisk stock target lifted by Citi on continued demand strength
• Keurig Dr Pepper upgraded at Barclays as breakup plan gains clarity
• Mistras Group expands Houston lab for aerospace and defense work